Self-antigen-specific CD8+ T cell precursor frequency determines the quality of the antitumor immune response.
Rizzuto GA, Merghoub T, Hirschhorn-Cymerman D, Liu C, Lesokhin AM, Sahawneh D, Zhong H, Panageas KS, Perales MA, Altan-Bonnet G, et al.
J Exp Med. 2009 Apr 13; 206(4):849-66. Epub 2009 Mar 30.
[J Exp Med. 2009]